Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Emotional Link LLC CEO Naoto Sato Interviews Associate Professor Mai Uchida, Harvard Medical School, on "How to deal with Blowing up on SNS"
2023-09-27 22:00
OBiO has launched its state-of-the-art GMP production facility Intelli-M to expedite innovative and advanced therapies to patients who are in need.
2023-09-27 21:00
SK Biopharmaceuticals' Proteovant Therapeutics Presents Preclinical Data on IKZF2 Protein Degrader Program and MOPED™ Molecular Glue Screening Platform at the 20th Annual Discovery on Target Conference
2023-09-27 08:30
ABM Therapeutics' ABM-1310 Granted Fast Track Designation by the FDA Following Orphan Drug Designation
2023-09-27 00:00
China Jo-Jo Drugstores Announces $2.59 Million Registered Direct Offering
2023-09-26 21:00
Actinogen optimizes XanaMIA Phase 2b Alzheimer's disease trial design and provides general business update
2023-09-26 20:51
WuXi Vaccines Launches Its First Vaccines CDMO Site in China
2023-09-26 15:41
Chime Biologics Enters into a Strategic Cooperation Agreement with Korea Kings Pharm to Accelerate the Biosimilar Launch
2023-09-25 20:15
Zhongchao Inc. Introduces PRO-Based Disease Management Model for Lung Cancer Patients
2023-09-25 20:00
Chinese Patent Granted for CytoMed Therapeutics' Licensed iPSC-Based Technology
2023-09-25 19:00
Xtep Unveils Milestone Brand Strategy Upgrade to Offer World-Class Running Shoes and Gears
2023-09-25 18:48
MediLink Therapeutics: Focuses on ADC research and development to promote new prospects for cancer treatment
2023-09-23 18:29
Concord Medical Reports Financial Results for the First Half of 2023
2023-09-23 05:00
Chime Biologics Announced Global Strategic Cooperation with Panolos Bioscience to Advance Multi-specific Therapeutic Proteins Development
2023-09-22 20:15
MicuRx receives FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designation for Contezolid and Contezolid acefosamil
2023-09-22 16:41
FDA Grants Fast Track Designation to 9MW3011
2023-09-22 08:00
Inmagene announces formation of Celexor Bio based on its anti-ILT7 mAb with enhanced pDC depletion function
2023-09-21 21:00
Golidocitinib Granted Priority Review by China NMPA for the Treatment of r/r PTCL
2023-09-21 20:26
VEDU Announces New Business Development and Management Team Changes
2023-09-21 20:00
AVANCE CLINICAL APPOINTS US-BASED EXECUTIVES - SVP SCIENTIFIC AND REGULATORY AFFAIRS, AND DIRECTOR BUSINESS DEVELOPMENT
2023-09-21 19:30
1
73
74
75
76
77
812